Novel paper sensor with modified aptamer for accurate detection of clinical cardiac troponin I
- 18 February 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (12) , 7412-7422
Abstract
Accurate and rapid detection of Cardiac Troponin I (CTnI) is essential for the early diagnosis and timely management of myocardial infarction (MI). However, conventional detection methods relying on antigen–antibody interactions often face challenges such as high costs and lengthy procedures. Novel detection methods based on antigen–aptamer interactions offer a potentially superior alternative. Nevertheless, the performance of antigen–aptamer sensors is typically compromised by the unstable structure of aptamers, resulting in limited sensitivity and inconsistent specificity in CTnI detection. To address these issues, we have developed an innovative aptamer structure to construct a paper-based sensor comprising a paper electrode and a CTnI aptamer detection module. The paper electrode employs PEDOT:PSS to uniformly distribute single-walled carbon nanotubes (SWCNTs) at high concentrations on filter paper. The detection module utilizes modified CTnI aptamers with a continuous (AT)5 sequence in the anchor domain to enhance stable immobilization on SWCNTs without chemical reactions. We discovered that incorporating appropriate 18-atom hexa-ethylene glycol spacers (Sp18) between the protein-capture and anchor domains of the aptamers can improve the sensitivity of the current response for CTnI detection. Through the optimization of annealing temperature and duration, the paper sensor Aps3-CTnI-PS@CP, which integrates (AT)5 and three Sp18 into the aptamer, demonstrated enhanced sensitivity and specificity for CTnI detection. When applied to clinical samples, Aps3-CTnI-PS@CP exhibited a favorable receiver operating characteristic (ROC) curve, with an area under the curve (AUC) of 0.982, a sensitivity of 0.917, and a specificity of 0.945 for CTnI detection. This performance correlates strongly with traditional chemiluminescence immunoassay (CLIA) assays used in clinical settings. The straightforward fabrication process and minimal batch-to-batch variability make Aps3-CTnI-PS@CP a promising candidate for clinical aptamer-based CTnI detection.Keywords
Funding Information
- National Natural Science Foundation of China (32430057)
- National Natural Science Foundation of China (U21A20173)
- National Natural Science Foundation of China (82204417)
This publication has 44 references indexed in Scilit:
- Hollow-like three-dimensional structure of methyl orange-delaminated Ti3C2 MXene nanocomposite for high-performance electrochemical sensing of tryptophanMicrochimica Acta, 2024
- Ti3C2 MXene-based nanozyme as coreaction accelerator for enhancing electrochemiluminescence of glucose biosensingBiosensors and Bioelectronics, 2024
- Improving aptamer performance: key factors and strategiesMicrochimica Acta, 2023
- Surface modification methods and mechanisms in carbon nanotubes dispersionCarbon, 2023
- A label-free multicolor colorimetric and fluorescence dual mode biosensing of HIV-1 DNA based on the bifunctional NiFe2O4@UiO-66 nanozymeAnalytica Chimica Acta, 2023
- Recent advances in aptamer applications for analytical biochemistryAnalytical Biochemistry, 2022
- Development of a novel ssDNA aptamer targeting cardiac troponin I and its clinical applicationsAnalytical and Bioanalytical Chemistry, 2021
- Electrochemical sensors for the detection of SARS-CoV-2 virusChemical Engineering Journal, 2021
- Perioperative Cardiovascular Risk Assessment and Management for Noncardiac SurgeryJAMA, 2020
- A Prostate Specific Antigen Immunosensor Based on Biotinylated‐Antibody/Cyclodextrin Inclusion Complex: Fabrication and Electrochemical StudiesElectroanalysis, 2017